QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Stopped Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention

Conditions

• Pancreatic Cancer

Interventions

• DRUG: Cyclophosphamide
• DRUG: Oxaliplatin
• DRUG: Capecitabine
• DRUG: 5-Fluorouracil
• DRUG: Leucovorin
• DRUG: nab-paclitaxel
• BIOLOGICAL: bevacizumab
• BIOLOGICAL: avelumab
• BIOLOGICAL: ALT-803
• BIOLOGICAL: aNK for Infusion
• BIOLOGICAL: ETBX-011
• BIOLOGICAL: GI-4000

Sponsor

ImmunityBio, Inc.